Latest Feature Article
Illumina Perspective on the Novel Coronavirus SARS-CoV-2 (2019-nCoV) Outbreak:
What We Know Today and Where Do We Go from Here
Feature Articles
Patients With Challenging Cancers to Benefit from Genomic Sequencing
University of Melbourne and Illumina Target Diagnosis of Difficult Cancers
Next-Generation Sequencing Helps Fight Infectious Diseases Globally
Case in Point: The Novel Coronavirus
Illumina Sequencers Help Characterize and Control Coronavirus
NGS Accelerating Viral Identification and Control Measures
The Weizmann Institute Uses NovaSeq to Drive Single Cell Research
By analyzing one cell at a time, Professor Amit is improving our understanding of biological systems in health and disease
Press Releases
In the News
| Date | Publication | Title |
|---|---|---|
| Feb 7, 2020 | CNBC | Illumina CMO on working with China on coronavirus cure |
| Feb 7, 2020 | The Smithsonian | How Simple Blood Tests Could Revolutionize Cancer Treatment |
| Jan 13, 2020 | CNBC | ILMN CEO at J.P. Morgan Healthcare Conference |
| Jan 3, 2020 | The Wall Street Journal | Illumina, Pacific Biosciences of California End Plans to Combine |
| Dec 3, 2019 | Yahoo! Finance | ArcherDX Announces Partnership with Illumina to Develop In-Vitro Diagnostic Tests |
Additional Resources
Investor Information
Careers at Illumina
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsPress Contacts
If you are a member of the media:
- Email pr@illumina.com
- Tel. 858.882.6822
If you are not a member of the media, please visit Contact Us.